Published in BMC Med on May 25, 2010
The representation of heart development in the gene ontology. Dev Biol (2011) 1.77
Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia. BMC Public Health (2013) 1.23
Racial discrimination & cardiovascular disease risk: my body my story study of 1005 US-born black and white community health center participants (US). PLoS One (2013) 0.90
Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999-2004. Int J Obes (Lond) (2015) 0.87
Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999-2004. Nutr Res (2015) 0.80
Clinical and imaging parameters to predict cardiovascular outcome in asymptomatic subjects. Int J Cardiovasc Imaging (2013) 0.80
Prevalence of weakness and its relationship with limitations based on the Foundations for the National Institutes for Health project: data from the Health and Retirement Study. Eur J Clin Nutr (2016) 0.80
Effect of bariatric surgery on cardiometabolic risk in elderly patients: A population-based study. Geriatr Gerontol Int (2015) 0.79
The role of carotid ultrasound for cardiovascular risk stratification beyond traditional risk factors. Yonsei Med J (2014) 0.78
Genetic risk score of NOS gene variants associated with myocardial infarction correlates with coronary incidence across Europe. PLoS One (2014) 0.77
Total cardiovascular risk for next 10 years among rural population of Nepal using WHO/ISH risk prediction chart. BMC Res Notes (2017) 0.75
Effect of Garlic and Lemon Juice Mixture on Lipid Profile and Some Cardiovascular Risk Factors in People 30-60 Years Old with Moderate Hyperlipidaemia: A Randomized Clinical Trial. Int J Prev Med (2016) 0.75
Genetic risk prediction for CKD: a journey of a thousand miles. Am J Kidney Dis (2012) 0.75
Adiponectin & inflammatory biomarkers in coronary artery disease. Indian J Med Res (2014) 0.75
The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease. Rambam Maimonides Med J (2015) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2007) 22.81
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care (1998) 18.69
Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med (2007) 18.45
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 16.95
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA (2003) 14.77
Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord (1998) 11.96
Long-term mortality after gastric bypass surgery. N Engl J Med (2007) 10.75
Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA (2004) 9.99
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) (2001) 8.45
Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation (1999) 8.13
C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation (2008) 7.33
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation (2002) 6.20
The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med (2006) 5.69
Changes in incidence of diabetes in U.S. adults, 1997-2003. Am J Prev Med (2006) 5.61
Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA (2004) 5.34
Tobacco use among adults--United States, 2005. MMWR Morb Mortal Wkly Rep (2006) 5.24
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation (1998) 4.89
Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ (2003) 4.74
Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA (2005) 4.22
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes (2002) 3.59
Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart (1999) 3.53
The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol (2004) 3.08
Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation (2001) 3.08
Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med (2005) 2.89
Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med (2002) 2.87
Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care (2005) 2.76
C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes (2008) 2.50
Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006. Circ Cardiovasc Qual Outcomes (2009) 2.17
Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care (1997) 2.05
An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health (2003) 1.96
Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial. Circulation (2009) 1.94
Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care (2007) 1.91
C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation (2004) 1.61
One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. CMAJ (2007) 1.55
Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels--a prospective and cross-sectional evaluation. Atherosclerosis (2002) 1.47
Trends in 10-year predicted risk of cardiovascular disease in the United States, 1976 to 2004. Circ Cardiovasc Qual Outcomes (2009) 1.35
Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. Am J Cardiol (2006) 1.24
Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol (2008) 1.24
Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery. Obesity (Silver Spring) (2007) 1.02
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet (2006) 8.61
Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc (2007) 3.12
Assessing adiposity: a scientific statement from the American Heart Association. Circulation (2011) 3.00
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J (2009) 2.71
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol (2011) 2.50
Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J (2007) 2.38
Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31
The national cholesterol education program diet vs a diet lower in carbohydrates and higher in protein and monounsaturated fat: a randomized trial. Arch Intern Med (2004) 2.24
Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nat Clin Pract Cardiovasc Med (2008) 1.84
Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest (2010) 1.79
ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur Heart J (2007) 1.67
Differentiating between body fat and lean mass-how should we measure obesity? Nat Clin Pract Endocrinol Metab (2008) 1.61
Participation in cardiac rehabilitation and survival after coronary artery bypass graft surgery: a community-based study. Circulation (2013) 1.54
Heart failure after myocardial infarction: prevalence of preserved left ventricular systolic function in the community. Am Heart J (2003) 1.53
Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol (2008) 1.50
Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis (2005) 1.50
Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest (2008) 1.47
Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial. Heart Rhythm (2011) 1.46
Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc (2013) 1.38
Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol (2007) 1.25
Sleep-disordered breathing, hypertension, and obesity in retired National Football League players. J Am Coll Cardiol (2010) 1.24
Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol (2008) 1.24
Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population. Am J Cardiol (2007) 1.19
Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil (2008) 1.16
Under-diagnosis of sleep apnea in patients after acute myocardial infarction. J Am Coll Cardiol (2010) 1.15
Normal weight obesity and mortality in United States subjects ≥60 years of age (from the Third National Health and Nutrition Examination Survey). Am J Cardiol (2013) 1.12
Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome. Am J Cardiol (2006) 1.10
Decreased right and left ventricular myocardial performance in obstructive sleep apnea. Chest (2007) 1.09
Obstructive sleep apnea, inflammation, and the metabolic syndrome. Metab Syndr Relat Disord (2009) 1.08
Abnormal cardiac structure and function in the metabolic syndrome: a population-based study. Mayo Clin Proc (2008) 1.07
Body mass index and risk of adverse cardiac events in elderly patients with hip fracture: a population-based study. J Am Geriatr Soc (2009) 1.07
Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc (2008) 1.06
Alcohol consumption and cardiovascular disease mortality in hypertensive men. Arch Intern Med (2004) 1.05
Nonalcoholic fatty liver disease and the coronary artery disease. Dig Dis Sci (2010) 1.05
Cardiovascular mortality in Hispanics compared to non-Hispanic whites: a systematic review and meta-analysis of the Hispanic paradox. Eur J Intern Med (2013) 1.04
Modest visceral fat gain causes endothelial dysfunction in healthy humans. J Am Coll Cardiol (2010) 1.04
Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery. Obesity (Silver Spring) (2007) 1.02
Combined effect of cardiorespiratory fitness and adiposity on mortality in patients with coronary artery disease. Am Heart J (2011) 0.99
Current status of cardiac rehabilitation in Latin America and the Caribbean. Am Heart J (2009) 0.99
Changes in left and right ventricular mechanics during the Mueller maneuver in healthy adults: a possible mechanism for abnormal cardiac function in patients with obstructive sleep apnea. Circ Cardiovasc Imaging (2010) 0.97
Self-efficacy after bariatric surgery for obesity. A population-based cohort study. Appetite (2009) 0.95
Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. Circulation (2015) 0.94
Availability and characteristics of cardiovascular rehabilitation programs in South America. J Cardiopulm Rehabil Prev (2013) 0.94
Medically diagnosed overweight and weight loss in a US national survey. Prev Med (2010) 0.90
Images in cardiovascular medicine. Percutaneous heart valve in the chronic in vitro testing model. Circulation (2002) 0.90
Epicardial adipose tissue: friendly companion or hazardous neighbour for adjacent coronary arteries? Eur Heart J (2008) 0.89
Obstructive sleep apnea and hypertension. Curr Cardiol Rep (2005) 0.89
Obesity paradox in different populations: evidence and controversies. Future Cardiol (2014) 0.88
IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome. Clin Sci (Lond) (2009) 0.88
Physician diagnosis of overweight status predicts attempted and successful weight loss in patients with cardiovascular disease and central obesity. Am Heart J (2010) 0.88
Impact of bariatric surgery on quality of life, functional capacity, and symptoms in patients with heart failure. Obes Surg (2013) 0.88
Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity. Am J Cardiol (2010) 0.86
Action on obesity: report of a mayo clinic national summit. Mayo Clin Proc (2005) 0.86
Diagnostic accuracy of the Berlin Questionnaire in detecting sleep-disordered breathing in patients with a recent myocardial infarction. Chest (2011) 0.85
Normal-weight obesity: implications for cardiovascular health. Curr Atheroscler Rep (2014) 0.85
Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: a systematic review. Rev Panam Salud Publica (2012) 0.85
Validity of weight loss to estimate improvement in body composition in individuals attending a wellness center. Obesity (Silver Spring) (2011) 0.85
ACEi/ARB for systolic heart failure: closing the quality gap with a sustainable intervention at an academic medical center. J Hosp Med (2011) 0.85
Changes in myocardial mechanics in patients with obesity following major weight loss after bariatric surgery. Obesity (Silver Spring) (2013) 0.84
Major weight loss prevents long-term left atrial enlargement in patients with morbid and extreme obesity. Eur J Echocardiogr (2008) 0.84
CXCR4+ and FLK-1+ identify circulating cells associated with improved cardiac function in patients following myocardial infarction. J Cardiovasc Transl Res (2013) 0.84
Outcome and cost-effectiveness of cardiopulmonary resuscitation after in-hospital cardiac arrest in octogenarians. Cardiology (2002) 0.83
Effect of a lifestyle therapy program using cardiac rehabilitation resources on metabolic syndrome components. J Cardiopulm Rehabil Prev (2013) 0.83
Relation of body mass index to fatal and nonfatal cardiovascular events after cardiac rehabilitation. Am J Cardiol (2005) 0.83
Inpatient rehabilitation outcomes for patients receiving left ventricular assist device. Am J Phys Med Rehabil (2014) 0.82
The current and potential capacity for cardiac rehabilitation utilization in the United States. J Cardiopulm Rehabil Prev (2014) 0.82
Functional aerobic capacity in patients with sleep-disordered breathing. Am J Cardiol (2013) 0.81
Association of body weight with total mortality and with ICD shocks among survivors of ventricular fibrillation in out-of-hospital cardiac arrest. Resuscitation (2008) 0.81
Mechanisms of adverse cardiometabolic consequences of obesity. Curr Atheroscler Rep (2013) 0.80
Quality indicators in cardiovascular care: the case for cardiac rehabilitation. J Cardiopulm Rehabil (2005) 0.80
Diagnostic performance of weight loss to predict body fatness improvement in cardiac rehabilitation patients. J Cardiopulm Rehabil Prev (2013) 0.79
Usefulness of epicardial adipose tissue as predictor of cardiovascular events in patients with coronary artery disease. Am J Cardiol (2012) 0.79
Impact of chronic changes in arterial compliance and resistance on left ventricular ageing in humans. Eur J Heart Fail (2014) 0.79
Quality of life after bariatric surgery: a population-based cohort study. Am J Med (2009) 0.79
CardioVision 2020: program acceptance and progress after 4 years. Am J Prev Med (2006) 0.79
Stress measures linking sleep apnea, hypertension and diabetes--AHI vs arousals vs hypoxemia. Sleep (2006) 0.79
Obesity and hypertrophic cardiomyopathy: chickens, eggs, and causality: clinical skills remain the key to caring for patients. J Am Coll Cardiol (2013) 0.78
Utility of different lipid measures to predict coronary heart disease. JAMA (2008) 0.78
A patient-centered decision rule for referral of patients to weight-loss programs. Qual Manag Health Care (2007) 0.78
Waist Circumference, Physical Activity, and Functional Impairments in Older U.S. Adults: Results from the NHANES 2005-2010. J Aging Phys Act (2014) 0.78
Impact of diagnosing metabolic syndrome on risk perception. Am J Health Behav (2012) 0.78
Participation Rates, Process Monitoring, and Quality Improvement Among Cardiac Rehabilitation Programs in the United States: A NATIONAL SURVEY. J Cardiopulm Rehabil Prev (2015) 0.77
Increased cardio-ankle vascular index in hyperlipidemic patients without diabetes or hypertension. J Atheroscler Thromb (2014) 0.77
Effect of cigar smoking on endothelium-dependent brachial artery dilation in healthy young adults. Am Heart J (2002) 0.77
The apolipoprotein b/apolipoprotein AI ratio in the metabolic syndrome-should we start using it? J Cardiometab Syndr (2008) 0.77
Threshold for diagnosing hypertension by automated office blood pressure using random sample population data. J Hypertens (2016) 0.77
Association of worksite wellness center attendance with weight loss and health care cost savings: Mayo Clinic's experience. J Occup Environ Med (2015) 0.76
Measuring faculty reflection on adverse patient events: development and initial validation of a case-based learning system. J Gen Intern Med (2010) 0.75
The pursuit of ideal cardiovascular health: an individual and societal challenge. Mayo Clin Proc (2012) 0.75
Reply: To PMID 23369419. J Am Coll Cardiol (2013) 0.75
High Stress and Negative Health Behaviors: A Five-Year Wellness Center Member Cohort Study. J Occup Environ Med (2016) 0.75
Screening for obstructive sleep apnea in early outpatient cardiac rehabilitation: feasibility and results. Sleep Med (2011) 0.75
The integration of studio cycling into a worksite stress management programme. Stress Health (2013) 0.75
Mayo Clinic office visit. Normal weight obesity. An interview with Francisco Lopez-Jimenez, M.D. Mayo Clin Womens Healthsource (2008) 0.75
Update in prevention of atherosclerotic heart disease: management of major cardiovascular risk factors. Rev Invest Clin (2006) 0.75
Metabolic syndrome and its components are underdiagnosed in cardiology clinics. J Eval Clin Pract (2010) 0.75
Normal-Weight Central Obesity and Mortality Risk. Ann Intern Med (2016) 0.75
Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association. Circulation (2017) 0.75